使用叙事和信息信息来改善惩戒专业人员对阿片类药物使用障碍的态度
Alyssa Harrell-Webber1, Xiaoquan Zhao2, Urszula A Horoszko1
1Department of Communication, George Mason University, Fairfax, USA.
Health & justice
|August 26, 2025
概括
在刑事司法系统的专业人士中改善了对阿片类药物使用障碍 (MOUD) 的态度. 对话和叙述形式在促进积极的MOUD态度和获取方面最有效.
科学领域:
- 公共卫生
- 刑事司法
- 行为科学
背景情况:
- 涉及刑事司法系统的人群中阿片类药物滥用和过量使用率很高.
- 在刑事法律环境中,对阿片类药物使用障碍 (MOUD) 的药物获取有限.
- 法律专业人士对MOUD的错误信息和负面态度,
研究的目的:
- 评估信息和叙事信息在处理错误信息和改善刑事司法系统专业人员对MOUD的态度方面的有效性.
- 评估不同信息格式 (信息,叙事,对话) 对MOUD访问的态度和支持的影响.
主要方法:
- 一项全国性的在线实验与502名刑事法律和行为健康专业人员进行.
- 参与者被随机分为四个条件:没有信息控制,信息信息,第一人称叙事信息或对话信息.
- 评估了对MOUD的态度,对访问的支持,叙事传输,感知到的现实主义和反驳.
主要成果:
- 与对照组相比,叙述和对话信息显著改善了对MOUD的态度.
- 对话信息也显著增加了对MOUD在惩戒设施的支持.
- 叙述的信息显示出更高的传输水平,
结论:
- 教育信息,特别是叙事和对话形式,可以有效地改善对MOUD的态度.
- 需要有针对性的干预措施来减少障碍,并促进刑事司法系统中MOUD的使用.
更多相关视频
12:20Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
Published on: June 10, 2013
21.3K
08:05A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
9.9K
相关概念视频
Drug Therapy
97
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
97
Analgesia and Pain Management
788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
Opioid Analgesics: Synthetic and Semisynthetic Opioids
426
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
426
Drug Abuse and Addiction: Pharmacological Phenomena
655
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
655
Opioid Analgesics: Morphine and Other Natural Cogeners
361
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
361
Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K
